Nathalie Nadal

机构：CHU Dijon Bourgogne · ORCID：0000-0001-8424-5141

发表论文 83 篇 · 总被引 1841 次 · h-index 25

代表论文

• Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial (2020 · Blood · 被引 136)
• NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis (2016 · Leukemia · 被引 135)
• PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies (2011 · British Journal of Haematology · 被引 60)
• Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53 (2019 · Blood · 被引 51)
• B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL (2019 · Frontiers in Oncology · 被引 43)
• The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH) (2022 · Leukemia · 被引 33)